Precipio, Inc. — Director's Dealing 2010

Sep 9, 2010

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TRANSGENOMIC INC (TBIO.OB)
CIK: 0001043961
Period of Report: 2009-12-11

Reporting Person: RICHARDS CHAD M (Senior VP, Sales & Marketing)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	24800	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Purchase Option	$0.69	2017-10-07	Common Stock (66667)		Direct
Purchase Option	$0.69	2017-10-07	Common Stock (66666)		Direct
Purchase Option	$0.69	2017-10-07	Common Stock (66667)		Direct

Footnotes

F1: Common Stock, par value $.01 per share of Transgenomic, Inc.